Almatroodi Saleh A, McDonald Christine F, Collins Allison L, Darby Ian A, Pouniotis Dodie S
Cancer and Tissue Repair Laboratory, School of Medical Sciences, RMIT University, Bundoora, VIC, Australia Applied Medical Sciences College, Qassim University, Buraidah, Saudi Arabia. E-mail:
Institute for Breathing and Sleep, Austin Health, Heidelberg, VIC, Australia.
Cancer Genomics Proteomics. 2015 Jan-Feb;12(1):39-48.
The most commonly reported primary lung cancer subtype is adenocarcinoma, which is associated with a poor prognosis and short survival. Proteomic studies on human body fluids such as bronchoalveolar lavage fluid (BALF) have become essential methods for biomarker discovery, examination of tumor pathways and investigation of potential treatments.
This study used quantitative proteomics to investigate the up-regulation of novel proteins in BALF from patients with primary lung adenocarcinoma in order to identify potential biomarkers.
BALF samples from individuals with and without primary lung adenocarcinoma were analyzed using liquid chromatography-mass spectrometry.
One thousand and one hundred proteins were identified, 33 of which were found to be consistently overexpressed in all lung adenocarcinoma samples compared to non-cancer controls. A number of overexpressed proteins have been previously shown to be related to lung cancer progression including S100-A8, annexin A1, annexin A2, thymidine phosphorylase and transglutaminase 2.
The overexpression of a number of specific proteins in BALF from patients with primary lung adenocarcinoma may be used as a potential biomarker for lung adenocarcinoma.
最常报告的原发性肺癌亚型是腺癌,其预后较差且生存期短。对支气管肺泡灌洗液(BALF)等人体体液进行蛋白质组学研究已成为发现生物标志物、检查肿瘤通路和研究潜在治疗方法的重要手段。
本研究采用定量蛋白质组学方法,研究原发性肺腺癌患者BALF中新型蛋白质的上调情况,以鉴定潜在的生物标志物。
使用液相色谱-质谱分析法对有和无原发性肺腺癌个体的BALF样本进行分析。
共鉴定出1100种蛋白质,其中33种在所有肺腺癌样本中均持续高表达,与非癌对照相比。先前已证明一些高表达蛋白质与肺癌进展相关,包括S100-A8、膜联蛋白A1、膜联蛋白A2、胸苷磷酸化酶和转谷氨酰胺酶2。
原发性肺腺癌患者BALF中多种特定蛋白质的过表达可能用作肺腺癌的潜在生物标志物。